investigated whether combining a vitamin D analog (paricalcitol) and an angiotensin receptor blocker (losartan) leads to more effective inhibition of the renin–angiotensin system and prevention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback